Most people taking Wegovy notice some appetite suppression within the first week or two of treatment, though the effect strengthens significantly over the first few months as the dose gradually increases. Semaglutide, Wegovy’s active ingredient, reaches peak levels in your blood within about 24 hours of each injection, so the biological machinery starts working almost immediately. But the full appetite-suppressing effect takes longer to build.
What Happens in Your Body After the First Injection
Semaglutide mimics a natural gut hormone called GLP-1 that your body releases after eating. This hormone activates receptors in the hypothalamus and brainstem, the parts of your brain that control hunger and fullness. By stimulating those same receptors at higher and more sustained levels than your body produces on its own, Wegovy dials down hunger signals and amplifies the feeling that you’ve had enough to eat.
After a subcutaneous injection, semaglutide reaches its peak concentration in about 24 hours, with a range of 3 to 48 hours depending on the person. Because the drug has a long half-life of roughly one week, it stays active between your weekly injections rather than wearing off and surging back. This steady presence is part of why the appetite effects feel consistent rather than coming and going.
The First Few Weeks: Subtle but Real
Wegovy uses a gradual dose escalation schedule that starts low and increases every four weeks. You begin at the lowest dose and don’t reach the full maintenance dose until month five. This slow ramp-up exists to minimize nausea and other gastrointestinal side effects, but it also means the appetite suppression builds incrementally.
During the first month at the starting dose, many people report a noticeable but modest decrease in hunger. You might find that portions feel more satisfying, that you stop eating sooner than usual, or that the urge to snack between meals fades. Some people feel this within the first few days. Others take two to three weeks to notice a clear difference. Individual variation is significant here, and factors like your baseline metabolism, body composition, and how sensitive your GLP-1 receptors are all play a role.
Months Two Through Five: The Ramp-Up Period
Each time your dose increases, you can expect another step up in appetite suppression. Many people describe the second and third months as the period when the effect becomes unmistakable. Meals that used to feel like a normal portion start to feel like too much food. The mental pull toward eating, even when you’re not physically hungry, begins to quiet down.
By the time you reach the full maintenance dose around month five, the appetite effect is typically at its strongest. Clinical trials showed that the majority of weight loss with semaglutide occurs in the first several months after reaching the maintenance dose, which aligns with peak appetite suppression during that window.
How “Food Noise” Changes
One of the most talked-about effects of Wegovy is the reduction in what people call “food noise,” the constant background hum of thoughts about food, cravings, and the mental negotiation around eating. This goes beyond physical hunger. It’s the difference between your stomach growling and your brain fixating on what you’ll eat next even though you just finished a meal.
A survey of people using semaglutide for weight management found striking changes in this experience. Before starting treatment, 47 to 63 percent of respondents agreed with statements describing persistent food-related thoughts and preoccupation. After initiating semaglutide, 59 to 68 percent actively disagreed with those same statements. That represents a 32 to 48 percentage point swing in the proportion of people experiencing intrusive food thoughts. Most participants in that survey had been on treatment for at least four months, suggesting that the full quieting of food noise takes some time to develop, even if early improvements start sooner.
This shift in mental bandwidth around food is often what people describe as the most life-changing part of the medication. Physical hunger reduction can happen in weeks, but the deeper cognitive change, where food simply stops dominating your attention, tends to consolidate over the first few months.
Why the Timeline Varies Between People
Not everyone follows the same trajectory. Some people feel dramatic appetite changes within days of their first injection, while others don’t notice much until they reach higher doses in month three or four. A few factors influence this:
- Starting weight and metabolic health. People with more insulin resistance sometimes report a slower onset of appetite effects, potentially because their hunger signaling is more disrupted at baseline.
- GLP-1 receptor sensitivity. Just as people respond differently to caffeine or alcohol, individual variation in receptor responsiveness affects how quickly and strongly semaglutide works.
- Side effects during titration. Nausea, which is common in the early weeks, can itself suppress appetite. Some people mistake nausea-driven food avoidance for the drug’s intended appetite effect. As nausea fades with dose adjustment, the true appetite suppression becomes easier to distinguish.
- Diet composition. People eating higher-protein meals often report that the satiety effects feel more pronounced, since protein and GLP-1 activation work through complementary pathways.
What to Realistically Expect
A rough timeline for most people looks like this: mild appetite reduction in weeks one through four, a more noticeable drop in hunger and portion sizes during months two and three, and full effect by months four to five when you’ve reached the maintenance dose. The quieting of food noise follows a similar but sometimes slightly slower arc.
If you’re several weeks in and don’t feel much difference yet, that’s within the normal range. The dose escalation schedule exists specifically because the lower doses aren’t expected to produce the full effect. Patience through the titration period is part of the design, not a sign that the medication isn’t working for you.